|
Volumn 91, Issue 1, 2001, Pages 126-131
|
Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells
a,b a,b a a a a,b c b a |
Author keywords
LRP; MDR; MRP; NaB; P gp; PAK 104; Reversal
|
Indexed keywords
5 (4,6 DIMETHYL 1,3,2 DIOXAPHOSPHORINAN 2 YL) 2,6 DIMETHYL 4 (3 NITROPHENYL) 3 PYRIDINECARBOXYLIC ACID 2 (4 BENZHYDRYL 1 PIPERAZINYL)ETHYL ESTER P OXIDE;
BUTYRIC ACID;
CEPHARANTHINE;
DOXORUBICIN;
ETOPOSIDE;
GLYCOPROTEIN P;
LUNG RESISTANCE PROTEIN;
MESSENGER RNA;
MULTIDRUG RESISTANCE PROTEIN;
PYRIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER RESISTANCE;
CARCINOMA CELL;
CELL NUCLEUS;
COLON CARCINOMA;
CONTROLLED STUDY;
DRUG ACCUMULATION;
DRUG TRANSPORT;
GENE EXPRESSION;
GENE OVEREXPRESSION;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
ALKALOIDS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BUTYRATES;
CARCINOMA;
CELL NUCLEUS;
COLONIC NEOPLASMS;
COLORING AGENTS;
CYCLIC P-OXIDES;
CYTOPLASM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXORUBICIN;
DRUG RESISTANCE, NEOPLASM;
ETOPOSIDE;
HUMANS;
MICROSCOPY, FLUORESCENCE;
NEOPLASM PROTEINS;
NICOTINIC ACIDS;
RNA, CATALYTIC;
TETRAZOLIUM SALTS;
THIAZOLES;
TIME FACTORS;
TUMOR CELLS, CULTURED;
VAULT RIBONUCLEOPROTEIN PARTICLES;
|
EID: 0035199820
PISSN: 00207136
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0215(20010101)91:1<126::AID-IJC1018>3.0.CO;2-8 Document Type: Article |
Times cited : (70)
|
References (28)
|